Compassionate Use Program at Medicity to Commence - Analyst Blog
December 04 2012 - 6:17AM
Zacks
Compassionate Use Program at Medicity to
Commence
By Brian Marckx, CFA
Aethlon Medical (AEMD) announced yesterday
(12/3/2012) that they have initiated a compassionate use program at
the Medicity Institute in India using Hemopurifier therapy in the
treatment of HCV. As a reminder, earlier this year the
Medicity IRB approved use of Hemopurifier in a compassionate use
program and in early October AEMD announced the protocol that will
govern treatment under this program.
With the initiation of treatment under compassionate use, this
will mark AEMD's initial foray into commercialization of
Hemopurifier. Yesterday's press release details the treatment
pricing ($7,235 for 3-day treatment, $2,295 each add'l day) and
reiterates the previously announced protocol and
inclusion/exclusion criteria.
As we've noted in earlier investor notes, the compassionate use
program should provide AEMD with another revenue stream (albeit
likely minimal, particularly at the outset) and potentially more
importantly, will increase the overall patient experience and
treatment volume which could bode well for increasing awareness of
Hemopurifier therapy and further bolster credibility of the
technology.
Treatment under this program is open to patients worldwide and
could potentially draw individuals from outside of India, including
the U.S. and Europe - AEMD notes Medicity is a leading center for
medical tourism.
For a free copy of the AEMD research report or additional research
on other small-cap stocks, please visit scr.zacks.com.
To become a subscriber to Zacks SCR and receive SCR blogs and
research reports emailed directly to your inbox, please visit our
Subscribe page.
AETHLON MEDICAL (AEMD): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Atlas Copco (PK) (USOTC:ATLRF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Atlas Copco (PK) (USOTC:ATLRF)
Historical Stock Chart
From Jul 2023 to Jul 2024